Inventor · disambiguated record
Kenji Egusa
Also filed as: EGUSA KENJI
9 granted patents·12 pending applications·102 citations·filing 2009–2024
88Inventor score
Top patents by PatentIndex Score
21 records- 0196US9415016B2DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2015·Granted Aug 16, 2016·30 cites·27 claims
- 0295US10973827B2DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2019·Granted Apr 13, 2021·9 cites·10 claims
- 0393US10596120B2Pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Mar 24, 2020·12 cites·22 claims
- 0493US9155705B2DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationFRIEDL THOMAS·Filed 2009·Granted Oct 13, 2015·42 cites·25 claims
- 0592US11564886B2Pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jan 31, 2023·2 cites·20 claims
- 0689US2024307403A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0786US2023338386A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0885US9555001B2Pharmaceutical composition and uses thereofITO MASANORI·Filed 2013·Granted Jan 31, 2017·6 cites·17 claims
- 0982US2022378797A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1077US12275722B2Process of reworking a crystalline form of a glycine transport inhibitorBOEHRINGER INGELHEIM INT·Filed 2021·Granted Apr 15, 2025·1 cites·7 claims
- 1176US2021196722A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1268US2020297639A1Pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1368US2022287980A1Pharmaceutical composition and uses thereofBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1467US2018289716A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1565US10022379B2DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jul 17, 2018·0 cites·20 claims
- 1662US2016310435A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 1758US10603292B2Pharmaceutical composition and pharmaceutical dosage form comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide, process for their preparation, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Granted Mar 31, 2020·0 cites·13 claims
- 1856US2013064887A1Pharmaceutical compositionsITO MASANORI·Filed 2012·Application pending·0 cites
- 1956US2016235680A1Pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 2047US2020188337A1Pharmaceutical composition and pharmaceutical dosage form comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide, process for their preparation, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2147US2017095424A1Pharmaceutical composition and uses thereofBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenji Egusa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →